Literature DB >> 2120637

Intraventricular infusions of antibodies to amyloid-beta-protein precursor impair the acquisition of a passive avoidance response in the rat.

E Doyle1, M T Bruce, K C Breen, D C Smith, B Anderton, C M Regan.   

Abstract

Intraventricular infusions of an antiserum raised against a 14 amino acid residue in the extracellular domain of amyloid-beta-protein precursor significantly decreased stepdown latency, at both 24 h and 48 h recall times, in rats trained to avoid an electroshock by remaining on a platform. The antiserum was effective when infused up to 2.5 h following training and no retention deficit was noted when it was administered at 4h or 6h after training. An antiserum generated against a 17 amino acid residue of the A4 amyloid peptide had no effect on learning. Thus the amyloid precursor protein, which is aberrantly processed in Alzheimer's disease, appears to be directly involved in memory formation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2120637     DOI: 10.1016/0304-3940(90)90524-d

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  22 in total

1.  Novel domain-specific actions of amyloid precursor protein on developing synapses.

Authors:  T Morimoto; I Ohsawa; C Takamura; M Ishiguro; Y Nakamura; S Kohsaka
Journal:  J Neurosci       Date:  1998-11-15       Impact factor: 6.167

2.  Memory-enhancing effects of secreted forms of the beta-amyloid precursor protein in normal and amnestic mice.

Authors:  H Meziane; J C Dodart; C Mathis; S Little; J Clemens; S M Paul; A Ungerer
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

Review 3.  The role of glycoproteins in neural development function, and disease.

Authors:  K C Breen; C M Coughlan; F D Hayes
Journal:  Mol Neurobiol       Date:  1998-04       Impact factor: 5.590

Review 4.  The role of the amyloid protein precursor (APP) in Alzheimer's disease: does the normal function of APP explain the topography of neurodegeneration?

Authors:  D H Small
Journal:  Neurochem Res       Date:  1998-05       Impact factor: 3.996

5.  Inhibition of protease-activated receptor 1 (PAR1) ameliorates cognitive performance and synaptic plasticity impairments in animal model of Alzheimer's diseases.

Authors:  Daruoosh Zare; Mohammad Amin Rajizadeh; Marzieh Maneshian; Hossein Jonaidi; Vahid Sheibani; Majid Asadi-Shekaari; Manouchehr Yousefi; Khadijeh Esmaeilpour
Journal:  Psychopharmacology (Berl)       Date:  2021-02-23       Impact factor: 4.530

6.  Cholinergic and dopaminergic agents which inhibit a passive avoidance response attenuate the paradigm-specific increases in NCAM sialylation state.

Authors:  E Doyle; C M Regan
Journal:  J Neural Transm Gen Sect       Date:  1993

7.  Characterization of the beta amyloid precursor protein-like gene in the central nervous system of the crab Chasmagnathus. Expression during memory consolidation.

Authors:  Maria Sol Fustiñana; Pablo Ariel; Noel Federman; Ramiro Freudenthal; Arturo Romano
Journal:  BMC Neurosci       Date:  2010-09-01       Impact factor: 3.288

8.  The chick as a model for the study of the cellular mechanisms and potential therapies for Alzheimer's disease.

Authors:  Radmila Mileusnic; Steven Rose
Journal:  Int J Alzheimers Dis       Date:  2010-07-18

Review 9.  Amyloid β precursor protein as a molecular target for amyloid β--induced neuronal degeneration in Alzheimer's disease.

Authors:  Elena Anahi Bignante; Florencia Heredia; Gerardo Morfini; Alfredo Lorenzo
Journal:  Neurobiol Aging       Date:  2013-05-25       Impact factor: 4.673

10.  Seizure susceptibility and mortality in mice that over-express amyloid precursor protein.

Authors:  Cara J Westmark; Pamela R Westmark; Ashley M Beard; Sharon M Hildebrandt; James S Malter
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.